These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7581698)

  • 1. Catalytic antibodies. Structure and possible applications.
    Amital H; Tur-Kaspa I; Tashma Z; Hendler I; Shoenfeld Y
    Methods Mol Biol; 1995; 51():203-10. PubMed ID: 7581698
    [No Abstract]   [Full Text] [Related]  

  • 2. [The antagonism of phosphorus-containing heterocyclics with the anticholinesterase agent Phosphacol (paraoxon)].
    Garaev RS
    Eksp Klin Farmakol; 1996; 59(1):68-70. PubMed ID: 8704640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Engineering of catalytic bioscavengers of organophosphorus compounds].
    Masson P; Nachon F; Rochu D
    Bull Acad Natl Med; 2007 Jan; 191(1):95-111; discussion 112. PubMed ID: 17645110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions.
    Topham CM; Gul S; Resmini M; Sonkaria S; Gallacher G; Brocklehurst K
    J Theor Biol; 2000 May; 204(2):239-56. PubMed ID: 10887904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An esterolytic antibody with vibrational properties of a catalytic H-chain and a non-catalytic L-chain.
    Havsteen BH
    J Theor Biol; 1999 Feb; 196(3):377-87. PubMed ID: 10049628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody AE-2 modulates carbamate and organophosphate inhibition of fetal bovine serum acetylcholinesterase.
    Wolfe AD; Chiang PK; Doctor BP; Fryar N; Rhee JP; Saeed M
    Mol Pharmacol; 1993 Dec; 44(6):1152-7. PubMed ID: 8264551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody catalysis. The key is in the pocket.
    Benkovic SJ
    Nature; 1996 Sep; 383(6595):23-4. PubMed ID: 8779708
    [No Abstract]   [Full Text] [Related]  

  • 8. Cation-π interaction: its role and relevance in chemistry, biology, and material science.
    Mahadevi AS; Sastry GN
    Chem Rev; 2013 Mar; 113(3):2100-38. PubMed ID: 23145968
    [No Abstract]   [Full Text] [Related]  

  • 9. Are specific hydrolases bioscavengers for defense against organophosphorus nerve agents?
    Bocedi AA; Ascenzi P
    IUBMB Life; 2003 Aug; 55(8):491-2. PubMed ID: 14609205
    [No Abstract]   [Full Text] [Related]  

  • 10. Catalytic antibodies: the rerouting of chemical reactions.
    Janda KD
    Biochem Soc Trans; 1993 Nov; 21(4):1090-5. PubMed ID: 8131905
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning.
    Masson P; Josse D; Lockridge O; Viguié N; Taupin C; Buhler C
    J Physiol Paris; 1998; 92(5-6):357-62. PubMed ID: 9789837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic promiscuity in biocatalysis: using old enzymes to form new bonds and follow new pathways.
    Bornscheuer UT; Kazlauskas RJ
    Angew Chem Int Ed Engl; 2004 Nov; 43(45):6032-40. PubMed ID: 15523680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic antibodies: designed and accidental.
    Suckling CJ; Stimson WH; Proctor GR; Bence LH; Brooks L; Khalaf AL; Tedford CM; Linaza S; McGilp I; Maguire R
    Biochem Soc Trans; 1993 Nov; 21(4):1099-102. PubMed ID: 8131907
    [No Abstract]   [Full Text] [Related]  

  • 14. Making enzymes.
    Lerner RA; Barbas CF; Janda KD
    Harvey Lect; 1996-1997; 92():1-40. PubMed ID: 15372741
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme inhibitors as chemical tools to study enzyme catalysis: rational design, synthesis, and applications.
    Hiratake J
    Chem Rec; 2005; 5(4):209-28. PubMed ID: 16041744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antidose therapy for organophosphate poisoning].
    Iseki K
    Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjugation of enzymes to antibodies.
    Winston SE; Fuller SA; Evelegh MJ; Hurrell JG
    Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.1. PubMed ID: 18265067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and stabilization of biocatalysts.
    Plou FJ; Ballesteros A
    Trends Biotechnol; 1999 Aug; 17(8):304-6. PubMed ID: 10507828
    [No Abstract]   [Full Text] [Related]  

  • 20. The chemistry of the antibody molecule.
    Schultz PG; Yin J; Lerner RA
    Angew Chem Int Ed Engl; 2002 Dec; 41(23):4427-37. PubMed ID: 12458503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.